Endocrine
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
1676 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 65 | 264 | 156 | 20 | 248 | 722 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 10 | 13 | 17 | 6 | 113 | 155 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 7 | 6 | 15 | 4 | 65 | 97 |
| Neoplasms | D009369 | — | C80 | 24 | 26 | 6 | 2 | 46 | 94 |
| Obesity | D009765 | EFO_0001073 | E66.9 | 2 | 5 | 3 | 1 | 63 | 74 |
| Syndrome | D013577 | — | — | 1 | 6 | 4 | 5 | 51 | 65 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 3 | 5 | 2 | 4 | 35 | 47 |
| Endocrine gland neoplasms | D004701 | EFO_0003769 | D35 | 2 | 10 | 4 | 1 | 31 | 45 |
| Male breast neoplasms | D018567 | — | — | 3 | 10 | 7 | 2 | 22 | 42 |
| Triple negative breast neoplasms | D064726 | — | — | 5 | 17 | 8 | 3 | 9 | 41 |
Show 72 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Carcinoma | D002277 | — | C80.0 | 6 | 16 | 8 | — | 10 | 37 |
| Prostatic neoplasms | D011471 | — | C61 | 3 | 9 | 7 | — | 12 | 29 |
| Osteoporosis | D010024 | EFO_0003882 | M81.0 | 5 | 4 | 2 | — | 18 | 27 |
| Recurrence | D012008 | — | — | 1 | 3 | 5 | — | 11 | 20 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | 1 | 3 | — | 12 | 15 |
| Overweight | D050177 | — | E66.3 | — | — | 1 | — | 13 | 14 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 5 | 5 | 1 | — | 4 | 13 |
| Hyperaldosteronism | D006929 | — | E26 | — | 1 | 2 | — | 11 | 13 |
| Cushing syndrome | D003480 | EFO_0003099 | E24 | — | 1 | 2 | — | 10 | 13 |
| Adenocarcinoma | D000230 | — | — | 2 | 5 | 3 | — | 2 | 11 |
Show 41 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | 1 | — | — | 19 | 20 |
| Multiple endocrine neoplasia | D009377 | — | E31.2 | 1 | 1 | — | — | 15 | 16 |
| Pituitary diseases | D010900 | — | E23.7 | — | 1 | — | — | 12 | 13 |
| Acromegaly | D000172 | — | — | 1 | 1 | — | — | 10 | 12 |
| Neuroendocrine carcinoma | D018278 | — | — | 3 | 6 | — | — | 3 | 9 |
| Brain neoplasms | D001932 | EFO_0003833 | C71 | 2 | 4 | — | — | 4 | 9 |
| Pheochromocytoma | D010673 | — | — | — | 3 | — | — | 5 | 8 |
| Covid-19 | D000086382 | — | U07.1 | — | 1 | — | — | 7 | 8 |
| Liver diseases | D008107 | EFO_0001421 | K70-K77 | — | 1 | — | — | 7 | 8 |
| Diabetic foot | D017719 | EFO_1001459 | — | — | 1 | — | — | 7 | 8 |
Show 92 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Body weight | D001835 | EFO_0004338 | — | 1 | — | — | — | 11 | 12 |
| Bone diseases | D001847 | — | M89.9 | 2 | — | — | — | 6 | 8 |
| Congenital adrenal hyperplasia | D000312 | — | E25.0 | 1 | — | — | — | 4 | 5 |
| Adrenogenital syndrome | D047808 | — | E25.9 | 1 | — | — | — | 4 | 5 |
| Alopecia | D000505 | — | L64 | 2 | — | — | — | 3 | 5 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 1 | — | — | — | 3 | 4 |
| Endocrine bone diseases | D001849 | — | — | 2 | — | — | — | 2 | 4 |
| Adrenocortical hyperfunction | D000308 | EFO_1000797 | — | 1 | — | — | — | 3 | 4 |
| Bone neoplasms | D001859 | EFO_0003820 | D16 | 2 | — | — | — | 1 | 3 |
| Hereditary breast and ovarian cancer syndrome | D061325 | — | — | 1 | — | — | — | 2 | 3 |
Show 25 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Metabolic diseases | D008659 | EFO_0000589 | E88.9 | — | — | — | — | 11 | 11 |
| Pediatric obesity | D063766 | — | — | — | — | — | — | 10 | 10 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | — | — | — | 8 | 8 |
| Morbid obesity | D009767 | EFO_0001074 | — | — | — | — | — | 8 | 8 |
| Infections | D007239 | EFO_0000544 | — | — | — | — | — | 8 | 8 |
| Prediabetic state | D011236 | EFO_1001121 | R73.03 | — | — | — | — | 8 | 8 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | — | — | 8 | 8 |
| Multiple endocrine neoplasia type 1 | D018761 | — | E31.21 | — | — | — | — | 7 | 7 |
| Hemorrhage | D006470 | MP_0001914 | R58 | — | — | — | — | 6 | 6 |
| Precocious puberty | D011629 | — | E22.8 | — | — | — | — | 6 | 6 |
Show 597 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use